Factors associated with screening positive for high falls risk in fragility fracture patients: a cross-sectional study.
Cross-sectional observational study
Deaths & Injuries)
Fragility fracture
Risk of falling
STEADI (Stopping Elderly Accidents
Journal
BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565
Informations de publication
Date de publication:
12 Jun 2020
12 Jun 2020
Historique:
received:
19
12
2019
accepted:
08
06
2020
entrez:
14
6
2020
pubmed:
14
6
2020
medline:
16
3
2021
Statut:
epublish
Résumé
We sought to report the prevalence of fragility fracture patients who were screened at high falls risk using a large provincial database, and to determine the characteristics associated with being screened at high falls risk. The study population included fragility fracture patients 50+ years of age who were screened at 35 hospital fracture clinics in Ontario over a 3.5 year period. The outcome was based on two screening questions measuring the risk of falling, both adapted from the STEADI (Stopping Elderly Accidents, Deaths & Injuries) tool. Multivariable associations of sociodemographic, fracture-related, and health-related characteristics were evaluated using logistic regression. Of the sample, 9735 (44.5%) patients were classified as being at high falls risk, and 12,089 (55.3%) were not. In the multivariable logistic regression, being 80+ years of age (vs. 50-64 years of age), non-community dwelling (vs. living with spouse, family member, roommate), having a mental/physical impairment (vs. none), and taking multiple medications, were all strongly associated with being screened at high falls risk. Living in a non-community dwelling and taking 4+ medications were the variables most strongly associated with being screened at high falls risk. These are potentially modifiable characteristics that should be considered when assessing falls risk in fragility fracture patients, and particularly when designing interventions for preventing subsequent falls. Ongoing work to address the higher risk of falls in the fragility fracture population is warranted.
Sections du résumé
BACKGROUND
BACKGROUND
We sought to report the prevalence of fragility fracture patients who were screened at high falls risk using a large provincial database, and to determine the characteristics associated with being screened at high falls risk.
METHODS
METHODS
The study population included fragility fracture patients 50+ years of age who were screened at 35 hospital fracture clinics in Ontario over a 3.5 year period. The outcome was based on two screening questions measuring the risk of falling, both adapted from the STEADI (Stopping Elderly Accidents, Deaths & Injuries) tool. Multivariable associations of sociodemographic, fracture-related, and health-related characteristics were evaluated using logistic regression.
RESULTS
RESULTS
Of the sample, 9735 (44.5%) patients were classified as being at high falls risk, and 12,089 (55.3%) were not. In the multivariable logistic regression, being 80+ years of age (vs. 50-64 years of age), non-community dwelling (vs. living with spouse, family member, roommate), having a mental/physical impairment (vs. none), and taking multiple medications, were all strongly associated with being screened at high falls risk.
CONCLUSIONS
CONCLUSIONS
Living in a non-community dwelling and taking 4+ medications were the variables most strongly associated with being screened at high falls risk. These are potentially modifiable characteristics that should be considered when assessing falls risk in fragility fracture patients, and particularly when designing interventions for preventing subsequent falls. Ongoing work to address the higher risk of falls in the fragility fracture population is warranted.
Identifiants
pubmed: 32532279
doi: 10.1186/s12891-020-03410-2
pii: 10.1186/s12891-020-03410-2
pmc: PMC7291444
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
372Références
JAMA. 2009 Feb 4;301(5):513-21
pubmed: 19190316
Am J Public Health. 2014 May;104(5):e77-84
pubmed: 24625164
Gerontologist. 2016 Apr 29;57(4):787-796
pubmed: 27130270
Cochrane Database Syst Rev. 2018 Jul 23;7:CD012221
pubmed: 30035305
Age Ageing. 2006 Sep;35 Suppl 2:ii37-ii41
pubmed: 16926202
Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004441
pubmed: 15674948
Curr Gerontol Geriatr Res. 2012;2012:864516
pubmed: 23304137
J Gerontol A Biol Sci Med Sci. 2006 Oct;61(10):1090-5
pubmed: 17077205
Osteoporos Int. 2010 Jun;21(6):903-8
pubmed: 20309525
BMC Geriatr. 2014 Aug 23;14:92
pubmed: 25151122
IHS Prim Care Provid. 2013 Sep;39(9):162-166
pubmed: 26766893
Postgrad Med. 2015 Apr;127(3):330-7
pubmed: 25539567
Maturitas. 2015 Sep;82(1):85-93
pubmed: 26255681
Arch Osteoporos. 2018 Mar 20;13(1):32
pubmed: 29558002
BMC Musculoskelet Disord. 2011 Jan 03;12:1
pubmed: 21199576
Osteoporos Int. 2006;17(3):417-25
pubmed: 16416256
J Epidemiol Community Health. 2017 Dec;71(12):1191-1197
pubmed: 28947669
Gerontologist. 2006 Dec;46(6):717-25
pubmed: 17169927
Am J Epidemiol. 2015 Apr 1;181(7):521-31
pubmed: 25700887
J Gerontol A Biol Sci Med Sci. 2009 May;64(5):599-609
pubmed: 19264957
JAMA Intern Med. 2016 Oct 1;176(10):1531-1538
pubmed: 27548843
Cochrane Database Syst Rev. 2012 Sep 12;(9):CD007146
pubmed: 22972103
Epidemiology. 2010 Sep;21(5):658-68
pubmed: 20585256
Phys Ther. 2005 Jul;85(7):648-55
pubmed: 15982171
Osteoporos Int. 2012 Mar;23(3):981-9
pubmed: 21523392
JAMA. 2018 Apr 24;319(16):1696-1704
pubmed: 29710141
CMAJ. 2010 Nov 23;182(17):1864-73
pubmed: 20940232
Physiother Can. 2013 Winter;65(1):31-9
pubmed: 24381379
Age Ageing. 2006 Sep;35 Suppl 2:ii60-ii64
pubmed: 16926208
Ann Pharmacother. 2012 Sep;46(9):1188-92
pubmed: 22872750
BMJ. 2010 Jul 08;341:c3324
pubmed: 20616099
Lancet. 2005 Nov 26;366(9500):1885-93
pubmed: 16310556
Osteoporos Int. 2008 Jan;19(1):79-86
pubmed: 17641811
Braz J Phys Ther. 2015 May-Jun;19(3):218-26
pubmed: 26083603
BMJ. 2003 Sep 27;327(7417):712-7
pubmed: 14512478
Z Gerontol Geriatr. 2006 Dec;39(6):451-61
pubmed: 17160740
Am J Prev Med. 2012 Jul;43(1):59-62
pubmed: 22704747
Inj Prev. 2004 Oct;10(5):308-13
pubmed: 15470013
Health Promot Pract. 2013 Sep;14(5):706-14
pubmed: 23159993
J Gerontol A Biol Sci Med Sci. 2007 Oct;62(10):1172-81
pubmed: 17921433